ATE246930T1 - Behandlung von chronischer viraler infektion mit m. vaccae - Google Patents

Behandlung von chronischer viraler infektion mit m. vaccae

Info

Publication number
ATE246930T1
ATE246930T1 AT00903857T AT00903857T ATE246930T1 AT E246930 T1 ATE246930 T1 AT E246930T1 AT 00903857 T AT00903857 T AT 00903857T AT 00903857 T AT00903857 T AT 00903857T AT E246930 T1 ATE246930 T1 AT E246930T1
Authority
AT
Austria
Prior art keywords
vaccae
treatment
viral infection
chronic viral
chronic
Prior art date
Application number
AT00903857T
Other languages
English (en)
Inventor
Cynthia Ann Stanford
Graham Arthur William Rook
Johnlawson Stanford
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Application granted granted Critical
Publication of ATE246930T1 publication Critical patent/ATE246930T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00903857T 1999-02-16 2000-02-16 Behandlung von chronischer viraler infektion mit m. vaccae ATE246930T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9903539.6A GB9903539D0 (en) 1999-02-16 1999-02-16 Therapy using M.Vaccae
PCT/GB2000/000544 WO2000048615A2 (en) 1999-02-16 2000-02-16 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE)

Publications (1)

Publication Number Publication Date
ATE246930T1 true ATE246930T1 (de) 2003-08-15

Family

ID=10847890

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00903857T ATE246930T1 (de) 1999-02-16 2000-02-16 Behandlung von chronischer viraler infektion mit m. vaccae

Country Status (26)

Country Link
US (1) US6596282B1 (de)
EP (1) EP1152768B1 (de)
JP (1) JP2002537266A (de)
KR (1) KR20010113691A (de)
CN (1) CN1377274A (de)
AP (1) AP2001002254A0 (de)
AT (1) ATE246930T1 (de)
AU (1) AU766113B2 (de)
BR (1) BR0008269A (de)
CA (1) CA2361925A1 (de)
DE (1) DE60004481T2 (de)
DK (1) DK1152768T3 (de)
ES (1) ES2204508T3 (de)
GB (1) GB9903539D0 (de)
HK (1) HK1038697B (de)
HU (1) HUP0105474A3 (de)
ID (1) ID30441A (de)
MX (1) MXPA01008243A (de)
NO (1) NO20013939L (de)
NZ (1) NZ513320A (de)
PL (1) PL350577A1 (de)
PT (1) PT1152768E (de)
RU (1) RU2001125429A (de)
TR (1) TR200102388T2 (de)
WO (1) WO2000048615A2 (de)
ZA (1) ZA200106248B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0010496D0 (en) * 2000-04-28 2000-06-14 Stanford Rook Ltd Treatment of conditions of the central nervous system
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
CN111281893B (zh) * 2020-03-02 2021-11-19 广西医科大学第一附属医院 注射用母牛分枝杆菌在制备用于防治covid-19的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917256D0 (en) 1989-07-28 1989-09-13 Univ London Biological preparation and its use
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8919321D0 (en) 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
CA2095855C (en) 1990-11-08 2003-04-29 Graham A.W. Rook Mycobacterium as adjuvant for antigens
EP1044273A2 (de) 1997-12-23 2000-10-18 Genesis Research & Development Corporation Limited Von mycobacterium vaccae abgeleitete zusammensetzungen und methoden für ihre verwendung

Also Published As

Publication number Publication date
AU766113B2 (en) 2003-10-09
AU2561100A (en) 2000-09-04
HK1038697A1 (en) 2002-03-28
ZA200106248B (en) 2002-01-23
ID30441A (id) 2001-12-06
WO2000048615A2 (en) 2000-08-24
EP1152768B1 (de) 2003-08-13
ES2204508T3 (es) 2004-05-01
CN1377274A (zh) 2002-10-30
TR200102388T2 (tr) 2002-10-21
CA2361925A1 (en) 2000-08-24
HK1038697B (en) 2004-03-19
RU2001125429A (ru) 2003-06-10
NO20013939L (no) 2001-10-04
NO20013939D0 (no) 2001-08-14
AP2001002254A0 (en) 2001-09-30
MXPA01008243A (es) 2002-08-30
DE60004481D1 (de) 2003-09-18
PL350577A1 (en) 2002-12-30
US6596282B1 (en) 2003-07-22
HUP0105474A3 (en) 2003-11-28
JP2002537266A (ja) 2002-11-05
EP1152768A2 (de) 2001-11-14
HUP0105474A2 (hu) 2002-05-29
DE60004481T2 (de) 2004-06-24
KR20010113691A (ko) 2001-12-28
NZ513320A (en) 2004-04-30
GB9903539D0 (en) 1999-04-07
WO2000048615A3 (en) 2000-12-14
BR0008269A (pt) 2001-11-06
PT1152768E (pt) 2003-12-31
DK1152768T3 (da) 2003-11-24

Similar Documents

Publication Publication Date Title
DE60001421D1 (de) Behandlung von abgas
DK1196172T3 (da) (S,S)-reboxetin til behandling af kronisk smerte
DE60113496D1 (de) Verwendung von Glycyrrhizin zur Behandlung von Mastitis.
DK1183269T3 (da) Svækkede mikroorganismer til behandlingen af infektion
DE60021065D1 (de) Virus behandlung
EP1117431A4 (de) Behandlung von acidose
DE60032884D1 (de) Blutbehandlungssystem
DK1242119T3 (da) Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosid
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
NO20013337L (no) Ny behandling
DE60103685D1 (de) Behandlung von Poriomania
DE60026821D1 (de) Behandlung von bohrspülung
ATE246930T1 (de) Behandlung von chronischer viraler infektion mit m. vaccae
NO20032769L (no) Kombinasjonsmetode for behandling av virale infeksjoner
ATE267598T1 (de) Virus behandlung
NO20022949D0 (no) Attenuerte mikroorganismer for behandling av infeksjon
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
DE60125035D1 (de) Behandlung von plasmid-haltigen lösungen
DE60103071D1 (de) Behandlung von flüssigkeiten
ATE459372T1 (de) Vorbeugung und behandlung von p. gingivalis infektion
BR0007433B1 (pt) seringa descartável autodestrutìvel.
DE10085032T1 (de) Behandlung von Nebenwirkungen
DE69100536D1 (de) Behandlung von abwasser.
ZA993346B (en) The treatment of viral infections.
EP1221951A4 (de) Behandlung von pankreas-erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1152768

Country of ref document: EP

REN Ceased due to non-payment of the annual fee